Sign in
4

Changes in Ownership

Protagonist Therapeutics, Inc Filed Acc 0001209191-21-014976

Chief Scientific Officer acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Liu David Y · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-26 Grant or award : show line 1 in the form +10,000 62,427 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-02-26 Grant or award : show line 2 in the form Stock Option (right to buy) +65,000 65,000 D
Loading xslF345X03/doc4.xml…